Revenues of leading global generics manufacturers 2018

With a revenue of more than 11 billion U.S. dollars, Mylan was the global leading generics manufacturer in 2018. Sandoz and Teva each generated close to 10 billion U.S. dollars that year, putting them in second and third place, respectively.

Generic prescription drugs

Worldwide generic prescription drug revenue is expected to increase in the coming years: the total amount of revenue generated in 2018 was roughly 75 billion U.S. dollars and is projected to reach 100 billion U.S. dollars by 2024. The revenue earned through the global prescribed generics market made up roughly nine percent of the total prescribed revenue in 2018. Branded prescription medication generally generates the highest revenue: in the U.S., branded drug revenue amounted to some 380 billion U.S. dollars in 2018.

Generic brands

A generic of a brand name drug lacks a widely recognized name. As a result, it tends to make them a cheaper alternative to the brand-name goods, as they are not usually advertised. Interestingly, generic drugs are sometimes created by the same manufacturers that create branded drugs.

Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2019



Survey time period


Supplementary notes

* Ranking by generic drug sales.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Generics and biosimilars"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.